#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Peritoneal neoplasm Homocystinuria Ewing's sarcoma recurrent Alternating hemiplegia of childhood VEXAS syndrome Thrombotic thrombocytopenic purpura Antiphospholipid antibodies Endometrial adenocarcinoma Immune-mediated myasthenia gravis Endocrine ophthalmopathy Acute respiratory distress syndrome White matter lesion Krabbe's disease Hypochromic anaemia Liposarcoma metastatic More trials…

    Learn about Rare Diseases

    Sjogren’s syndrome – Basic Information Brain stem glioma Glomerulonephritis rapidly progressive – Diagnostics Methylmalonic acidaemia – Treatment Behcet’s syndrome Antithrombin III deficiency – Diagnostics Carcinoid syndrome Angiosarcoma recurrent – Basic Information Alternating hemiplegia of childhood – Treatment Retinitis pigmentosa – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    VALACICLOVIR HYDROCHLORIDE ETX-19477 Db-1303 Magnesium Sulfate Heptahydrate Corylus Avellana L. Myrrh Vinblastine Sulfate Cemiplimab Desflurane Iptacopan Icatibant Lasn01 Sotalol Hydrochloride Elinzanetant Calcium Chloride Festuca Rubra Pollen Eribulin Mesylate Fulvestrant Atezolizumab Lebrikizumab More therapies…

    Learn about Your Condition

    Fracture infection Drug use disorder Deafness traumatic Juvenile absence epilepsy Adenovirus infection Neuroblastoma recurrent Heparin resistance Acute leukaemia Addison's disease Acne Polycystic liver disease Paraganglion neoplasm Atopic keratoconjunctivitis Adenocarcinoma gastric Small cell carcinoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Asthma

  • Study on the Effectiveness and Safety of AZD4604 for Adults with Moderate-to-Severe Asthma Uncontrolled on Medium-High Dose ICS-LABA

    Not recruiting

    2 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • (2R)-N-[3-(5-Fluoro-2-{[2-Fluoro-3-(Methylsulfonyl)Phenyl]Amino}-4-Pyrimidinyl)-1H-Indol-7-Yl]-3-Methoxy-2-(4-Methyl-1-Piperazinyl)Propanamide-1-Hydroxy-2-Naphthoic Acid
    Bulgaria Denmark France Germany The Netherlands Spain +1

  • Study on the Effectiveness and Safety of Budesonide, Glycopyrronium, and Formoterol Inhaler for Adults and Adolescents with Severe Asthma Not Well Controlled

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Formoterol Fumarate Dihydrate
    • Salbutamol
    • Budesonide
    Bulgaria Hungary Italy Poland Romania Spain

  • Study on Long-Term Safety of Depemokimab for Adults and Adolescents with Severe Eosinophilic Asthma

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Depemokimab
    Czechia France Germany Hungary Italy Poland +1

  • Study on the Effects of Dexpramipexole for Adolescents and Adults with Severe Eosinophilic Asthma

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Dexpramipexole Dihydrochloride Monohydrate
    • Salbutamol Sulfate Ph. Eur.
    • Formoterol Fumarate Dihydrate
    Austria Croatia Czechia France Germany Hungary +3

  • Study on the Effectiveness and Safety of Budesonide, Glycopyrronium, and Formoterol Inhaler for Adults and Adolescents with Severe Asthma

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Formoterol Fumarate Dihydrate
    • Salbutamol
    • Budesonide
    Czechia Germany Greece Portugal Slovakia

  • Study on the Effects of Benralizumab on Lung Function in Patients with Severe Eosinophilic Asthma

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Benralizumab
    Denmark Sweden
Previous Page
1 … 8 9 10 11 12 … 14
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!